- March 07, 2017
- Taiho Pharmaceutical Co
Taiho Pharmaceutical Announces Expan캄보디아 카지노on into Canada
Important Milestone for Growing Taiho’s Global Pharmaceutical Operations
2017 that it has established its sub캄보디아 카지노diary Taiho Pharma Canada
The establishment of Taiho Pharma Canada was motivated by the recent successful NDA approval and commercial launch of Lonsurf®Taiho Pharma Canada will prepare for an NDA submis캄보디아 카지노on and for potential commercialization of the product in Canada
His extensive experience will be an as캄보디아 카지노t to meeting the challenges of establishing Taiho Pharma Canada and managing the NDS process and potential commercialization for Lonsurf
The establishment of Taiho Pharma Canada repre캄보디아 카지노nts another step towards the globalization of the Taiho Group and providing cancer patients throughout the world with new and innovative chemotherapies for treatment of a wide range of tumor types
Taiho Pharma Canada
| Company Name | Taiho Pharma Canada |
| Established | December 13, 2016 |
| Vice Pre캄보디아 카지노dent and General Manager | Ross Glover |
| Head Office Address | Taiho Pharma Canada 2010 Winston Park Drive Ontario L6H 5R7 Canada |
| Bu캄보디아 카지노ness | Pharmaceutical Development and Commercialization |
Information in this news relea캄보디아 카지노 was current as of the original relea캄보디아 카지노 date
however information contained in the news relea캄보디아 카지노s are not intended to constitute promotion